J Korean Endocr Soc.  2007 Apr;22(2):95-97. 10.3803/jkes.2007.22.2.95.

The Significance of Immunohistochemical Staining in Thyroid Nodule: TPO and Galectin-3

• Gong G

• KMID: 1523088
• DOI: http://doi.org/10.3803/jkes.2007.22.2.95

Abstract

No abstract available.

MeSH Terms

Galectin 3*
Thyroid Gland*
Thyroid Nodule*
Galectin 3

Reference

1. Garcia-Mayor RV, Perez Mendez LF, Paramo C, Luna Cano R, Reqo Iraeta A, Reqal M, Sierra JM, Fluiters E. Fine needle aspiration biopsy of thyroid nodules: impact on clinical practive. J Endocrinol Invest. 1997. 20:482–487.

2. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology. 2002. 40:80–87.

3. Rosai J. Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori. 2003. 89:517–519.

4. Ghali VS, Jimenez EJ, Garcia RL. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol. 1992. 23:21–25.

5. Aratake Y, Kotani T, Tamura K, Araki Y, Kuribayashi T, Konoe K, Ohtaki S. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol. 1991. 96:306–310.

6. Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors: Potential diagnostic implications. Am J Pathol. 1995. 147:815–822.

7. Gasbarri A, Martegani MP, Prete F, Lucante T, Natali PG, Bartolazzi A. Galectin-3 and CD44v6 Isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol. 1999. 17:3494–3502.

8. Bae GH, Yoon HD, Bae JY, Son HS, Jung ED, Hong SP, Kim MH, Lee SA, Kim HS, Ahn SY. Galectin-3 and Thyroid Peroxidase Expression in Thyroid Nodules. J Kor Endocrine Soc. 2007. 22:105–111.

9. Weber K, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyrpid cancer. Am J Clin Pathol. 2004. 122:524–531.

10. Christensen L, Blichert-Toft M, Brandt M, Lange M, Sneppen SB, Ravnsbaek J, Mollerup CL, Strange L, Jensen F, Kirkegaard J, Sand Hansen H, Sorensen SS, Feldt-Rasmussen U. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. Clin Endocrinol (Oxf). 2000. 53:161–169.

11. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsso O. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001. 357:1644–1650.

12. Saggiorato E, Capia S, Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F. Glaectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab. 2001. 86:5152–5158.

13. Inohara H, Honijo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer. 1999. 85:2475–2484.

14. Kovacs RB, Földes J, Winkler G, Bodó M, Sápi Z. The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol. 2003. 149:449–453.

15. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM, Baloch ZW. Iuumnohistochemical Expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med. 2002. 126:710–713.

16. Papotti M, Volante M, Saggiorato E, Deandreis D, Vertri A, Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol. 2002. 147:515–552.

17. Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006. 50:28–34.